PJ, February 2019, Vol 302, No 7922

Pharmacists should do more to help patients with OTC analgesics, experts say

Experts in pain management attended a round-table event to discuss how pharmacists and the pharmacy team can better support patients to self-manage acute pain with over-the-counter treatments.…

Supported content

The GP pharmacists leading a life-saving medicines safety project

A major initiative by pharmacists to reduce risky medicines use in the community will be rolled out across the country after it was found to reduce serious adverse events.…

Train not blame: how one hospital trust boosted error reporting by over 100%

Wrightington, Wigan and Leigh NHS Foundation Trust has dramatically improved medicines safety through pharmacy-led initiatives to address mistakes in prescribing and improve error reporting.…

Comprehensive guide to identifying diseases caused by drug therapy

Drug-induced Diseases: Prevention, Detection, and Management, edited by James E Tisdale and Douglas A Miller.…

How to investigate and manage a medication incident

Of the nearly 237 million medication errors occurring in England each year, 28% have the potential to cause harm. This article outlines the immediate steps to be taken following identification of a medicines safety incident.…

FMD system goes down on its first working weekday

The computer system for the Falsified Medicines Directive crashed on the first weekday morning since after its 9 February 2019 launch.…

GPhC expects more than 2,000 pharmacists to leave the register by end of 2018/2019

More than 2,000 pharmacists are expected to leave the pharmacy register in 2019, according to forecasts from the General Pharmaceutical Council.…

Falsified Medicines Directive is yet another casualty of Brexit

It is understandable that pharmacists are reluctant to buy expensive equipment and change their workflows to comply with the Falsified Medicines Directive when the legislation may no longer apply after Brexit.…

EMA recommends sartan manufacturers review processes to avoid contamination

The European Medicines Agency has recommended that manufacturers making sartan blood pressure medicines review their processes after impurities were found in a small number of products.…

Share your views on the future of your journals

The Pharmaceutical Journal and Clinical Pharmacist have a proud history of providing members with the best possible content in print and online. But the world is changing and we need help from you, our members, to ensure we continue to meet your needs. We are currently investigating …